Wells Fargo & Company Aclaris Therapeutics, Inc. Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 25,858 shares of ACRS stock, worth $32,839. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,858

Previous 20,079 28.78%

Holding current value

$32,839

Previous $21,000 52.38%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.92 - $1.44 $5,316 - $8,321	5,779 Added 28.78%	25,858 $32,000
Q4 2023 Feb 09, 2024	BUY	$0.64 - $6.49 $1,146 - $11,630	1,792 Added 9.8%	20,079 $21,000
Q3 2023 Nov 13, 2023	SELL	$6.56 - $10.95 $91,052 - $151,986	-13,880 Reduced 43.15%	18,287 $125,000
Q2 2023 Aug 15, 2023	BUY	$7.89 - $10.64 $118,231 - $159,440	14,985 Added 87.21%	32,167 $333,000
Q1 2023 May 12, 2023	BUY	$7.07 - $17.95 $67,843 - $172,248	9,596 Added 126.5%	17,182 $139,000

Q4 2022 Feb 13, 2023	BUY	$14.33 - $18.37 $21,151 - $27,114	1,476 Added 24.16%	7,586 $119,000
Q3 2022 Nov 14, 2022	SELL	$13.07 - $18.22 $2,836 - $3,953	-217 Reduced 3.43%	6,110 $97,000
Q2 2022 Aug 12, 2022	SELL	$10.16 - $17.08 $340,197 - $571,906	-33,484 Reduced 84.11%	6,327 $89,000
Q1 2022 May 16, 2022	BUY	$9.74 - $17.92 $68,306 - $125,672	7,013 Added 21.38%	39,811 $686,000
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.49 $1.08 Million - $1.62 Million	-87,751 Reduced 72.79%	32,798 $477,000
Q3 2021 Nov 15, 2021	BUY	$13.38 - $18.8 $1.6 Million - $2.25 Million	119,438 Added 10750.5%	120,549 $2.17 Million
Q2 2021 Aug 16, 2021	SELL	$17.08 - $29.6 $4,765 - $8,258	-279 Reduced 20.07%	1,111 $20,000
Q1 2021 May 13, 2021	SELL	$5.86 - $27.73 $184,859 - $874,770	-31,546 Reduced 95.78%	1,390 $35,000
Q4 2020 Feb 09, 2021	BUY	$2.65 - $7.61 $84,055 - $241,381	31,719 Added 2606.33%	32,936 $213,000
Q3 2020 Nov 05, 2020	SELL	$1.5 - $2.71 $1,528 - $2,761	-1,019 Reduced 45.57%	1,217 $4,000
Q2 2020 Aug 13, 2020	SELL	$1.04 - $1.73 $52,118 - $86,697	-50,114 Reduced 95.73%	2,236 $3,000
Q1 2020 May 14, 2020	BUY	$0.75 - $2.18 $39,262 - $114,123	52,350 New	52,350 $54,000

Others Institutions Holding ACRS

# of Institutions

102

Shares Held

53.5M

Call Options Held

51K

Put Options Held

31.6K

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $84.7M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Aclaris Therapeutics, Inc. Transaction History